CR Double-Crane: North Pharmaceutical's equity structure changes

China Resources Double-Crane Pharmaceutical (SSE:600062) announced that the equity structure of its controlling shareholder, Beijing Pharmaceutical Group (North Pharmaceutical Group), has undergone a change. The original holder of 51% of North Pharmaceutical Group's shares, China Resources Pharmaceutical Investment Co., Ltd., has transferred these shares without compensation to China Resources Pharmaceutical Holdings Co., Ltd. This transfer has been completed with industrial and commercial registration procedures. Despite the change, North Pharmaceutical Group remains the controlling shareholder of China Resources Double-Crane, and China Resources Co., Ltd. remains the actual controller of the company. The company emphasizes that this change will not impact its governance structure or operating activities. Detailed information regarding the equity change is available in the abridged equity change report disclosed by China Resources Pharmaceutical Investment Co., Ltd. on the Shanghai Stock Exchange website.